Supplemental Materials for JAAD Publication JAAD-D-21-01712R3, Phase 2 Randomized, Dose-Ranging Trial of CTP-543, a Selective Janus Kinase Inhibitor, in Moderate to Severe Alopecia Areata

These are supplemental data sets to the JAAD publication entitled "Phase 2 Randomized, Dose-Ranging Trial of CTP-543, a Selective Janus Kinase Inhibitor, in Moderate to Severe Alopecia Areata". Supplemental figures include: Figure S1: Enrollment and Patient Disposition; Figure S2: Patient SALT Improvement Thresholds; Figure S3: Percentage of Patients Achieving SALT score ≤20 Over Treatment Period; Figure S4. Patient-Reported Outcomes.